Divisione Onc Med dell'Azienda

Udine, Friuli Venezia Giulia 33100

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed